Search Results - Peter Dreger

Refine Results
  1. 1
    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation

    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation by Thomas Luft, Peter Dreger, Aleksandar Radujkovic

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter]

    Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] by Peter Dreger, Meinolf Suttorp, Torsten Haferlach, H. Löffler, Norbert Schmitz, W Schroyens

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effects of physical exercise on survival after allogeneic stem cell transplantation

    Effects of physical exercise on survival after allogeneic stem cell transplantation by Joachim Wiskemann, Nikolaus Kleindienst, Rea Kuehl, Peter Dreger, Rainer Schwerdtfeger, Martin Bohus

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter]

    Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [letter] by Peter Dreger, Meinolf Suttorp, Torsten Haferlach, H. Löffler, N Schmitz, W Schroyens

    Published 1993
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Chimeric antigen receptor transduced T cells: Tuning up for the next generation

    Chimeric antigen receptor transduced T cells: Tuning up for the next generation by Maria‐Luisa Schubert, Jean‐Marc Hoffmann, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?

    Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? by Peter Dreger, Timothy S. Fenske, Silvia Montoto, Marcelo C. Pasquini, Anna Sureda, Mehdi Hamadani

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

    Autologous progenitor cell transplantation: prior exposure to stem cell- toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow gra... by Peter Dreger, M. Kloss, Bodil Petersen, Torsten Haferlach, H. Löffler, M. Loeffler, N Schmitz

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

    Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments] by Norbert Schmitz, Peter Dreger, Meinolf Suttorp, EB Rohwedder, Torsten Haferlach, H. Löffler, Ann Hunter, NH Russell

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation

    Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation by Joachim Wiskemann, Peter Dreger, Rainer Schwerdtfeger, Andrea Bondong, Gerhard Huber, Nikolaus Kleindienst, Cornelia M. Ulrich, Martin Bohus

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Cell-based immunotherapy approaches for multiple myeloma

    Cell-based immunotherapy approaches for multiple myeloma by Katharina Kriegsmann, Mark Kriegsmann, Martin Cremer, Michael Schmitt, Peter Dreger, Hartmut Goldschmidt, Carsten Müller‐Tidow, Michael Hundemer

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

    Side-effect management of chimeric antigen receptor (CAR) T-cell therapy by Maria‐Luisa Schubert, Michael Schmitt, L. Wang, Carlos A. Ramos, Karin Jordan, Carsten Müller‐Tidow, Peter Dreger

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia

    Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia by Matthias Ritgen, Alexandra Lange, Stephan Stilgenbauer, Hartmut Döhner, Christian Bretscher, Heidi Bosse, Ariane Stuhr, Michael Kneba, Peter Dreger

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)

    Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML) by Susanne Hofmann, Maria‐Luisa Schubert, Lei Wang, Bailin He, Brigitte Neuber, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma

    Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma by Clara Kolbe, Joseph Kauer, Berit J. Brinkmann, Peter Dreger, Wolfgang Huber, Carsten Müller‐Tidow, Sascha Dietrich, Tobias Roider

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product

    Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product by Peter Dreger, Patrick Marquardt, Torsten Haferlach, S. Jacobs, T Mülverstedt, Volker Eckstein, Meinolf Suttorp, H. Löffler, W Müller-Ruchholtz, Norbert Schmitz

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

    Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation by H. Euler, A Marmont, Andrea Bacigalupo, S. Fastenrath, Peter Dreger, M. Hoffknecht, AR Zander, Berthold Schalke, Uwe Hahn, R Haas, N Schmitz

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment

    Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment by Sascha Dietrich, Christine S. Falk, Axel Benner, Suzan Karamustafa, Esther Hahn, Mindaugas Andrulis, Ute Hegenbart, Anthony D. Ho, Peter Dreger, Thomas Luft

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    GSK-3 mediates differentiation and activation of proinflammatory dendritic cells

    GSK-3 mediates differentiation and activation of proinflammatory dendritic cells by Elena Rodionova, Michael Conzelmann, Eugene Maraskovsky, Michael Heß, Michael Kirsch, Thomas Giese, Anthony D. Ho, Margot Zöller, Peter Dreger, Thomas Luft

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD

    Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD by Markus Zeisbrich, Natália Becker, Axel Benner, Aleksandar Radujkovic, Katrin Schmitt, Jörg Beimler, Anthony D. Ho, Martin Zeier, Peter Dreger, Thomas Luft

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

    High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies by Peter Dreger, Paolo Ghia, Johannes Schetelig, Michel van Gelder, Eva Kimby, Mauricette Michallet, Carol Moreno, Tadeusz Robak, Stephan Stilgenbauer, Emili Montserrat

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: